Accession Number: | 0001209191-23-010523 |
Date: | 2023-02-15 |
Issuer: | VERA THERAPEUTICS, INC. (VERA) |
Original Submission Date: |
GRANT SEAN
C/O VERA THERAPEUTICS, INC.
8000 MARINA BOULEVARD, SUITE 120
BRISBANE, CA 94005
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 7.87 | 2023-02-15 | deemed execution date | A | 200,000 (a) | 2033-02-14 | class a common stock 200,000 | $7.87 | 200,000 | direct |
ID | footnote |
---|---|
f1 | 1/48 of the total stock option will vest and become exercisable monthly on the same day of each month following february 15, 2023, subject to continuous service of the reporting person on each vesting date. |